Peptide Research Collection Library
Explore the compound
Quick Facts
Mechanism of Action
Formulation: This premixed research formulation contains GHK-CU 50 mg, KPV 10 mg, BPC 157 10 mg.
Evidence context: Evidence for individual components and evidence for the combined formulation are tracked separately; findings for one component should not be assumed to establish effects for the mixture.
- Supports collagen, elastin, and extracellular-matrix signaling in skin and tissue research [1].
- Associated with wound-repair and tissue-remodeling pathways in biomedical literature [1].
- Commonly discussed for skin firmness, texture, and appearance-support benefits tied to copper-peptide biology [1].
- Supports antioxidant and anti-inflammatory pathway research in cellular and tissue models [3].
Blend Composition
Listed ingredient quantities represent the contents of the full vial, not an amount to administer. This formulation is supplied as a liquid; no reconstitution is needed.
| Ingredient | Listed quantity per vial |
|---|---|
| GHK-CU | 50 mg |
| KPV | 10 mg |
| BPC 157 | 10 mg |
Research Applications & Context
GHK-Cu protocol overview: tissue-remodeling and skin-support research model using 3 mL reconstitution planning.
Research Dosage Information
Reported research quantities and their source context. These are not recommendations, and source status varies.
Scroll the table horizontally to read every column. Select a row to inspect it in the calculator.
Dosing protocol: common research schedules use either a 5-days-per-week gradual approach or a simplified 3-times-weekly approach.
| Phase | Reported Amount | Frequency | Draw Units | Cycle | Notes | Calculator |
|---|---|---|---|---|---|---|
| Weeks 1-4 | 1.0 mg | Once daily, 5 days/week | Select a vial | 4 weeks | Standard / gradual conservative research row. | |
| Weeks 5-8 | 1.5 mg | Once daily, 5 days/week | Select a vial | 4 weeks | Standard / gradual escalation research row. | |
| Weeks 9-12+ | 2.0 mg | Once daily, 5 days/week | Select a vial | 4+ weeks / study-specific | Standard / gradual target research row. | |
| Alternative schedule | 2.0 mg | 3 times weekly | Select a vial | 8-12 weeks or study-specific | Alternative research scheduling row. |
Dosing Protocol & Schedule
These are mathematical planning summaries derived from reported rows already in the research library. Community-reported schedules are not clinical or validated protocols, recommendations, or directions for human use.
| Include | Phase | Research Dose | Frequency | Weeks | Entries | Total quantity | Volume per entry | U-100 equivalent |
|---|---|---|---|---|---|---|---|---|
| Weeks 1-4 | 1.0 mg | Once daily, 5 days/week | 4 | — | — | — | — | |
| Weeks 5-8 | 1.5 mg | Once daily, 5 days/week | 4 | — | — | — | — | |
| Weeks 9-12+ | 2.0 mg | Once daily, 5 days/week | 4 | — | — | — | — | |
| Alternative schedule | 2.0 mg | 3 times weekly | 12 | — | — | — | — |
Plan a Regimen Schedule
Save the selected research protocol to your private calendar. Scheduled entries never create Dose Logs.
Reconstitution Calculator
Select the vial strength you are examining. The reference chart displays examples, not recommended preparation volumes or validated protocols.
Reconstitution Reference Chart
Hypothetical volume comparisons for the selected vial. No particular volume is endorsed, and vial capacity, solubility, excipients and product-specific instructions are not established by this table.
| Example volume | Calculated concentration | Calculator |
|---|---|---|
| 1 mL | — | |
| 2 mL | — | |
| 3 mL | — | |
| 4 mL | — | |
| 5 mL | — |
Choose a compatible dry vial to see reference concentrations.
Research-only mathematical comparisons; not instructions to compound, prepare, or administer peptides. Community-reported protocols are not clinically validated by inclusion here.
Supplies Needed — Estimate
Select a vial strength and an example reconstitution volume below. Counts use only the checked, computable rows above; they are not product-specific sterility, compatibility, or stability guidance.
Select a compatible vial and volume below to view quantities.
Educational and entertainment purposes only. Research use only; not for human or animal administration. Pad counts assume two per Total entry; syringe counts include additional containers where a single entry exceeds the selected syringe capacity. Vial totals assume full theoretical recovery and do not account for dead volume, spoilage, asepsis, expiration, potency, route, or beyond-use dating. These figures are not a recommended supplies list for an actual procedure.
Published References (0 identified)
A recorded identifier identifies a publication; it does not establish that its claims have been independently verified.
Research indexes & other source links
Searches, registries and unverified source records are discovery resources, not verified published studies.
- PubMed.gov biomedical literature: GHK-CU +KPV +BPC 157 Blend View source ↗ PubMed index/search · Source link recorded; claim verification separate
- ClinicalTrials.gov study registry: GHK-CU +KPV +BPC 157 Blend View source ↗ ClinicalTrials.gov registry/search · Source link recorded; claim verification separate
- NIH/NCBI all-databases search: GHK-CU +KPV +BPC 157 Blend View source ↗ NCBI database/search · Source link recorded; claim verification separate
- PubChem / NIH compound record search: GHK-CU +KPV +BPC 157 Blend View source ↗ PubChem database/search · Source link recorded; claim verification separate
